EyePoint (EYPT) Work In Process (2018 - 2026)

EyePoint (EYPT) posted Work In Process of $84000.0 for Q1 2026, down 85.62% sequentially from $584000.0 in Q4 2025, and down 75.22% YoY from $339000.0 in Q1 2025.

EyePoint (EYPT) Work In Process (2018 - 2026) Analysis & Trends

EyePoint has reported Work In Process for 9 years, with the latest figure at $84000.0 in Q1 2026.

  • Quarterly Work In Process fell 75.22% year-over-year to $84000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $84000.0 (down 75.22% YoY) and the FY2025 annual result came in at $584000.0, down 9.88% from the prior year.
  • Work In Process declined to $84000.0 in Q1 2026 per EYPT's latest filing, from $584000.0 in the prior quarter.
  • Over five years, Work In Process peaked at $1.9 million in Q3 2023 and troughed at $84000.0 in Q1 2026.
  • A 5-year average of $869529.4 and a median of $854000.0 in 2022 frame the typical range for Work In Process.
  • The sharpest annual moves came in 2022 and 2026: Work In Process soared 288.89% in 2022, then tumbled 75.22% in 2026.
  • Over 5 years, Work In Process stood at $1.1 million in 2022, then dropped by 18.18% to $882000.0 in 2023, then retreated by 26.53% to $648000.0 in 2024, then fell by 9.88% to $584000.0 in 2025, then slumped by 85.62% to $84000.0 in 2026.
  • According to Business Quant data, Work In Process over the past three periods registered $84000.0, $584000.0, and $498000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 EyePoint 1.25 Bn 1.07 Bn 507,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 764,000.00
Mar 31, 2026 84,000.00
Dec 31, 2025 584,000.00
Sep 30, 2025 498,000.00
Jun 30, 2025 1.00 Mn
Mar 31, 2025 339,000.00
Dec 31, 2024 648,000.00
Sep 30, 2024 649,000.00
Jun 30, 2024 921,000.00
Mar 31, 2024 1.09 Mn
Dec 31, 2023 882,000.00
Sep 30, 2023 1.86 Mn
Jun 30, 2023 1.43 Mn
Mar 31, 2023 1.60 Mn
Dec 31, 2022 1.08 Mn
Sep 30, 2022 854,000.00
Jun 30, 2022 595,000.00
Mar 31, 2022 671,000.00
Dec 31, 2021 405,000.00
Sep 30, 2021 571,000.00